melatonin has been researched along with Myelodysplastic Syndromes in 1 studies
Myelodysplastic Syndromes: Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Viviani, S | 1 |
| Negretti, E | 1 |
| Orazi, A | 1 |
| Sozzi, G | 1 |
| Santoro, A | 1 |
| Lissoni, P | 1 |
| Esposti, G | 1 |
| Fraschini, F | 1 |
1 other study available for melatonin and Myelodysplastic Syndromes
| Article | Year |
|---|---|
Preliminary studies on melatonin in the treatment of myelodysplastic syndromes following cancer chemotherapy.
Topics: Aged; Antineoplastic Agents; Blood Cell Count; Female; Humans; Male; Melatonin; Middle Aged; Myelody | 1990 |